Cell-adhesion-dependent influences on genomic instability and carcinogenesis

Current Opinion in Cell Biology

Volumn 10, Issue 5, 1998, Pages 647-653

  Tlsty, Thea D ^a  

^a H ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; CELL ADHESION MOLECULE; INTEGRIN; PROTEIN P53;

ANIMAL CELL; CANCER GROWTH; CARCINOGENESIS; CELL ADHESION; CELL CYCLE; CELL INVASION; CELL MIGRATION; CELL TRANSFORMATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ANIMALIA;

EID: 0031698240     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(98)80041-0     Document Type: Article

References (50)

1. Birchmeier W, Behrens J. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta. 1198:1994;11-26.
2. Hermiston ML, Gordon JI. In vivo analysis of cadherin function in the mouse intestinal epithelium: essential roles in adhesion, maintenance of differentiation, and regulation of programmed cell death. J Cell Biol. 129:1995;489-506.
3. Takeichi M. Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol. 5:1993;806-811.
4. Yap AS. The morphogenetic role of cadherin cell adhesion molecules in human cancer: a thematic review. Cancer Invest. 16:1998;252-261.
5. Frenette PS, Wagner DD. Molecular medicine adhesion molecules-part 1. N Engl J Med. 334:1996;1526-1529.
6. Willert K, Nusse R. β-catenin: a key mediator of Wnt signaling. of special interest Curr Opin Genet Dev. 8:1998;95-102 This review provides an excellent overview of complex adhesion-dependent signaling pathways.
7. Barth AI, Nathke IS, Nelson WJ. Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways. Curr Opin Cell Biol. 5:1997;683-690.
8. Juliano RL, Haskill S. Signal transduction from the extracellular matrix. J Cell Biol. 120:1993;577-585.
9. Behrens J, Mareel MM, Van Roy FM, Birchmeier W. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol. 108:1989;2435-2447.
10. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Lochner D, Birchmeier W. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol. 113:1991;173-185.
11. Vleminckx K, Vakaet L Jr, Mareel M, Fiers W, van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell. 66:1991;107-119.
12. Saunders RJ, Mainiero F, Giancotti FG. The role of integrins in tumorigenesis and metastasis. Cancer Investigation. 16:1998;329-344.
13. Risinger JI, Berchuck A, Kohler MF, Boyd J. Mutations of the E-cadherin gene in human gynecologic cancers. Nat Genet. 7:1994;98-102.
14. Oda T, Kanai Y, Oyama T, Yoshiura K, Shimoyama Y, Birchmeier W, Sugimura T, Hirohashi S. E-cadherin gene mutations in human gastric carcinoma cell lines. Proc Natl Acad Sci USA. 91:1994;1858-1862.
15. Ilyas M, Tomlinson PM. The interactions of APC, E-cadherin and β-catenin in tumour development and progression. J Pathol. 182:1997;128-137.
16. Yoshiura K, Kanai Y, Ochiai A, Shimoyama Y, Sugimura T, Hirohashi S. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci USA. 92:1995;7416-7419.
17. Berx G, Cleton-Jansen AM, Strumane K, de Leeuw WJ, Nollet F, van Roy F, Cornelisse C. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene. 13:1996;1919-1925.
18. Pierceall WE, Woodard AS, Morrow JS, Rimm D, Fearon ER. Frequent alterations in E-cadherin and alpha- and beta-catenin expression in human breast cancer cell lines. Oncogene. 11:1995;1319-1326.
19. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW. Activation of beta-catenin-TCF signaling in colon cancer by mutations in beta-catenin or APC. Science. 275:1997;1787-1790.
20. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P. Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science. 275:1997;1790-1792.
21. Sparks AB, Morin PJ, Vogelstein B, Kinzler KW. Mutational analysis of the APC/beta-catenin/TCF pathway in colorectal cancer. Cancer Res. 58:1998;1130-1134.
22. Hermiston ML, Wong MH, Gordon JI. Forced expression of E-cadherin in the mouse intestinal epithelium slows cell migration and provides evidence for nonautonomous regulation of cell fate in a self-renewing system. Genes Dev. 10:1996;985-996.
23. Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma. of outstanding interest Nature. 392:1998;190-193 This paper demonstrates for the first time that loss of cellular adhesion is a causal event in tumor progression rather than simply a consequence.
24. Wong MH, Hermiston ML, Syder AJ, Gordon JI. Forced expression of the tumor suppressor adenomatosis polyposis coli protein induces disordered cell migration in the intestinal epithelium. Proc Natl Acad Sci USA. 93:1996;9588-9593.
25. Rubinfeld B, Souza B, Albert I, Muller O, Chamberlain SH, Masiarz FR, Munemitsu S, Polakis P. Association of the APC gene product with beta-catenin. Science. 262:1993;1731-1734.
26. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A, Reeve AE. E-cadherin germline mutations in familial gastric cancer. of outstanding interest Nature. 392:1998;402-405 Documents the involvement of the major adhesion protein E-cadherin in the initiation of cancer.
27. McClatchey AI, Saotome I, Mercer K, Crowley D, Gusella JF, Bronson RT, Jacks T. Mice heterozygous for a mutation at the NF2 tumor suppressor locus develop a range of highly metastatic tumors. of outstanding interest Genes Dev. 12:1998;1121-1133 This paper suggests the involvement of the merlin protein in tumor initiation.
28. Grunwald GB. The structural and functional analysis of cadherin calcium-dependent cell adhesion molecules. Curr Opin Cell Biol. 5:1993;797-805.
29. Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K. A novel moesin-ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell. 75:1993;826.
30. Huynh DP, Pulst SM. Neurofibromatosis 2 antisense oligodeoxynucleotides induce reversible inhibition of schwannomin synthesis and cell adhesion in STS26T and T98G cells. Oncogene. 13:1996;73-84.
31. Lutchman M, Rouleau GA. The neurofibromatosis type 2 gene product, schwannomin, suppresses growth of NIH 3T3 cells. Cancer Res. 55:1995;2270-2274.
32. Shaw RJ, McClatchey AI, Jacks T. Regulation of the neurofibromatosis type 2 tumor suppressor protein, merlin, by adhesion and growth arrest stimuli. of special interest J Biol Chem. 273:1998;7757-7764 The absence of merlin function is suggested to result in inappropriate cell cycle entry, lack of response to arrest signals and continued proliferation of the mutant cells.
33. Tong X, Howley PM. The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton. of special interest Proc Natl Acad Sci USA. 94:1997;4412-4417 A new association between an adhesion molecule and viral oncoproteins and evidence for its importance in tumor transformation is described here.
34. Schaller MD, Otey CA, Hildebrand JD, Parsons JT. Focal adhesion kinase and paxillin bind to peptides mimicking beta integrin cytoplasmic domains. J Cell Biol. 130:1995;1181-1187.
35. Weng Z, Taylor JA, Turner CE, Brugge JS, Seidel-Dugan C. Detection of Src homology 3-binding proteins, including paxillin, in normal and v-Src-transformed Balb/c 3T3 cells. J Biol Chem. 268:1993;14956-14963.
36. Birge RB, Fajardo JE, Reichman C, Shoelson SE, Songyang Z, Cantley LC, Hanafusa H. Identification and characterization of a high-affinity interaction between v-Crk and tyrosine-phosphorylated paxillin in CT10-transformed fibroblasts. Mol Cell Biol. 13:1993;4648-4656.
37. Salgia R, Li JL, Lo SH, Brunkhorst B, Kansas GS, Sobhany ES, Sun Y, Pisick E, Hallek M, Ernst T. Molecular cloning of human paxillin, a focal adhesion protein phosphorylated by P210BCR/ABL. J Biol Chem. 270:1995;5039-5047.
38. Tachibana K, Sato T, D'Avirro N, Morimoto C. Direct association of pp125FAK with paxillin, the focal adhesion-targeting mechanism of pp125FAK. J Exp Med. 182:1995;1089-1099.
39. Wood CK, Turner CE, Jackson P, Critchley DR. Characterisation of the paxillin-binding site and the C-terminal focal adhesion targeting sequence in vinculin. J Cell Sci. 107:1994;709-717.
40. Assoain RK. Anchorage-dependent cell cycle progression. J Cell Biol. 136:1997;1-4.
41. Assoian RK, Zhu X. Cell anchorage and the cytoskeleton as partners in growth factor dependent cell cycle progression. Curr Opin Cell Biol. 9:1997;93-98.
42. Frisch SM, Ruoslahti E. Integrins and anolkis. Curr Opin Cell Biol. 9:1997;701-706.
43. Giancotti FG. Integrin signaling: specificity and control of cell survival and cell cycle progression. Curr Opin Cell Biol. 9:1997;691-700.
44. Hartwell LH, Weinert TA. Checkpoints: controls that ensure the order of cell cycle events. Science. 246:1989;629-634.
45. Gadbois DM, Bradbury EM, Lehnert BE. Control of radiation-induced G1 arrest by cell-substratum interactions. of special interest Cancer Res. 57:1997;1151-1156 Intriguing results are presented in this paper that suggest that cell cycle arrest mechanisms may be 'reset' by loss of cellular adhesion.
46. Nigro JM, Aldape KD, Hess SM, Tlsty TD. Cellular adhesion regulates p53 protein levels in primary human keratinocytes. of special interest Cancer Res. 57:1997;3635-3639 This paper provides the first example of adhesion effects on p53 protein levels in normal human cells. This paper suggests that adhesion has potential to tie into several different pathways.
47. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA. 89:1992;7491-7495.
48. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tlsty TD. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell. 70:1992;923-935.
49. Ko LJ, Prives C. p53: puzzle and paradigm. Genes Dev. 10:1996;1054-1072.
50. Levine AJ. The tumor suppressor genes. Annu Rev Biochem. 62:1993;623-651.